1. Home
  2. PAYX vs TAK Comparison

PAYX vs TAK Comparison

Compare PAYX & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Paychex Inc.

PAYX

Paychex Inc.

HOLD

Current Price

$111.63

Market Cap

45.6B

ML Signal

HOLD

Logo Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

TAK

Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

HOLD

Current Price

$14.22

Market Cap

43.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAYX
TAK
Founded
1979
1781
Country
United States
Japan
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.6B
43.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PAYX
TAK
Price
$111.63
$14.22
Analyst Decision
Hold
Analyst Count
12
0
Target Price
$141.08
N/A
AVG Volume (30 Days)
3.0M
3.0M
Earning Date
12-19-2025
10-30-2025
Dividend Yield
3.85%
3.72%
EPS Growth
N/A
N/A
EPS
4.46
0.14
Revenue
$5,793,200,000.00
$29,846,840,032.00
Revenue This Year
$19.55
N/A
Revenue Next Year
$5.93
$0.59
P/E Ratio
$25.13
$200.55
Revenue Growth
9.08
N/A
52 Week Low
$108.00
$12.80
52 Week High
$161.24
$15.69

Technical Indicators

Market Signals
Indicator
PAYX
TAK
Relative Strength Index (RSI) 43.37 49.90
Support Level $109.75 $14.16
Resistance Level $114.15 $14.42
Average True Range (ATR) 2.09 0.14
MACD 0.73 -0.00
Stochastic Oscillator 62.25 42.08

Price Performance

Historical Comparison
PAYX
TAK

About PAYX Paychex Inc.

Paychex is a technology company providing human capital management solutions, enabling clients to better implement payroll, talent, time, tax, and benefits administration. It has a diverse set of product offerings addressing client needs. Aside from its traditional cloud-based payroll and HCM software offering, which accounts for close to half of total revenue, the company provides outsourcing options. Paychex's administrative service organization and professional employer organization accounts generate over 40% of sales. The balance of revenue is generated through retirement services, insurance solutions, and other products. In fiscal 2025, the company had 800,000 clients and almost 2.5 million worksite employees across its ASO and PEO.

About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

Share on Social Networks: